Combined anti-inflammatory agent
Patent 5095037 Issued on March 10, 1992. Estimated Expiration Date: 
December 6, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 6, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesRemote administration of hyaluronic acid to mammals Patent #: 4808576 InventorsAssigneeApplicationNo. 623318 filed on 12/06/1990US Classes:514/561Nitrogen other than as nitro or nitroso nonionically bondedExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/195Foreign Application Priority Data1989-12-21 JPAbstractA pharmaceutical composition for treating inflammatory diseases, comprising (A) an effective amount of hyaluronic acid or its salt, and (B) an effective amount of an anti-inflammatory agent. The composition exhibits a synergistic therapeutic effect on inflammations and is useful for treating inflammatory diseases, particularly diseases of joint with inflammation.Other References
Field of SearchNitrogen other than as nitro or nitroso nonionically bonded | |
